JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


228	Mon, 8/1/2011, 2:00 PM - 3:50 PM	CC-A205
The Use of Historical Data Priors in the Design and Analysis of Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section , Section on Health Policy Statistics
Organizer(s): David Ohlssen, Novartis
Chair(s): David Ohlssen, Novartis
2:05 PM	Evaluating Probability of Study Success Through Bayesian Evidence — Haoda Fu, Eli Lilly and Company
2:25 PM	A Bayesian Adaptive Dose Selection Procedure with a Count Endpoint — Luca Pozzi, University of California at Berkeley ; Heinz Schmidli, Novartis Pharma AG ; Mauro Gasparini, Politecnico di Torino ; Amy Racine, Novartis
2:45 PM	From Historical Data to Priors — Beat Neuenschwander, Novartis Pharma AG
3:05 PM	Examples of Safety and Efficacy Analyses in Early Clinical Development Incorporating Historical Data — Neal Thomas, Pfizer Inc.
3:25 PM	Discussant: Ram C. Tiwari, U.S. Food and Drug Administration/CDER/OTS/OB
3:45 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.